Related Experiment Video
Updated: Jun 22, 2025
The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues
Published on: June 16, 2018
Immunonutrition, Metabolism, and Programmed Cell Death in Lung Cancer: Translating Bench to Bedside
Palma Fedele1, Anna Natalizia Santoro1, Francesca Pini1
1Oncology Unit, Dario Camberlingo Hospital, 72021 Francavilla Fontana, Italy.
Abstract:
Lung cancer presents significant therapeutic challenges, motivating the exploration of novel treatment strategies. Programmed cell death (PCD) mechanisms, encompassing apoptosis, autophagy, and programmed necrosis, are pivotal in lung cancer pathogenesis and the treatment response. Dysregulation of these pathways contributes to tumor progression and therapy resistance. Immunonutrition, employing specific nutrients to modulate immune function, and metabolic reprogramming, a hallmark of cancer cells, offer promising avenues for intervention. Nutritional interventions, such as omega-3 fatty acids, exert modulatory effects on PCD pathways in cancer cells, while targeting metabolic pathways implicated in apoptosis regulation represents a compelling therapeutic approach. Clinical evidence supports the role of immunonutritional interventions, including omega-3 fatty acids, in augmenting PCD and enhancing treatment outcomes in patients with lung cancer. Furthermore, synthetic analogs of natural compounds, such as resveratrol, demonstrate promising anticancer properties by modulating apoptotic signaling pathways. This review underscores the convergence of immunonutrition, metabolism, and PCD pathways in lung cancer biology, emphasizing the potential for therapeutic exploration in this complex disease. Further elucidation of the specific molecular mechanisms governing these interactions is imperative for translating these findings into clinical practice and improving lung cancer management.
Insights
Novel lung cancer treatments explore programmed cell death (PCD) and immunonutrition. Omega-3 fatty acids and metabolic targeting show promise in enhancing PCD and improving patient outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- Lung cancer poses significant therapeutic challenges, with programmed cell death (PCD) pathways playing a critical role in its progression and response to treatment.
- Dysregulation of apoptosis, autophagy, and programmed necrosis contributes to tumor growth and resistance to therapies.
- Metabolic reprogramming and immune modulation are key hallmarks of cancer cells offering potential intervention points.
Purpose of the Study:
- To review the interplay between immunonutrition, metabolic reprogramming, and PCD mechanisms in lung cancer.
- To highlight the therapeutic potential of targeting these pathways for improved lung cancer management.
- To explore the role of specific nutrients and compounds in modulating cancer cell death.
Main Methods:
- Literature review focusing on studies investigating immunonutrition, cancer metabolism, and programmed cell death in lung cancer.
- Analysis of research on nutritional interventions like omega-3 fatty acids and compounds such as resveratrol.
- Examination of clinical evidence supporting immunonutritional strategies in lung cancer treatment.
Main Results:
- Immunonutrition, particularly omega-3 fatty acids, can modulate PCD pathways in lung cancer cells.
- Targeting cancer cell metabolism offers a promising strategy for inducing apoptosis.
- Clinical data suggests immunonutritional interventions can enhance PCD and treatment outcomes in lung cancer patients.
- Resveratrol and similar compounds show potential by influencing apoptotic signaling.
Conclusions:
- The convergence of immunonutrition, metabolism, and PCD pathways presents a promising area for novel lung cancer therapies.
- Further research into the molecular mechanisms underlying these interactions is crucial for clinical translation.
- Integrating nutritional and metabolic strategies could significantly improve lung cancer treatment and patient outcomes.
More Related Videos
06:03Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
Published on: January 19, 2019
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
Related Concept Videos
01:27Tumor Immunotherapy
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
01:22PI3K/mTOR/AKT Signaling Pathway
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...